HHS Leadership Signals Major Policy Shifts: Prior Authorization Reform, Vaccine Schedule Changes, and Medicaid Fraud Crackdown Take Center Stage

A clear pattern of aggressive policy reform is emerging from the HHS under Secretary Kennedy's leadership, with simultaneous actions across multiple fronts that will reshape healthcare delivery and payment systems. The deferral of $259.5M in Medicaid funding to Minnesota, coupled with new prior authorization pain points and vaccine schedule modifications, suggests a fundamental restructuring of healthcare administration. The integration trend continues with Cigna's strategic acquisition of CarepathRx, while the FDA under Commissioner Makary is taking an notably stringent stance on rare disease drug approvals. These developments collectively point to a regulatory environment prioritizing cost control and administrative streamlining, though potentially at the expense of treatment access and provider flexibility.